Director, 10% Owner · Bambusa Therapeutics, Inc. · Bambusa Therapeutics, Inc. — Series A-2 Preferred Stock
Side
C
Value
—
Shares
160.9K
Price
—
Executed
Nov 2, 2026
Disclosed
Nov 2, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Nov 2 executedNov 2, 2026 disclosed
BBTX · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Derivative conversion — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Bambusa Therapeutics, Inc. — Series A-2 Preferred Stock
Ticker
BBTX
Shares
160.9K
Price per share
$0
Execution date (reported)
Nov 2, 2026
Owned after transaction
0 shares
Days from execution to publication
0
What this establishes
Jeggle Helmut Wolfgang filed this Form 4 reporting a derivative conversion of BBTX on Nov 2, 2026. It became public on Nov 2, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, 10% Owner
Jeggle Helmut Wolfgangcik:0001982614
Issuer
Bambusa Therapeutics, Inc.cik:0002044950
Revision history · 0
No field has changed since this record was first ingested.
